SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on September 22, 2022. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut. The filing discloses a material event under Regulation FD regarding a product launch.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate announcement rather than financial performance data.
Material Changes
The primary material event reported is the launch of the PURE EP Software Version 6 with the ACCUVIZ Module. This announcement was made via a press release attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this filing. The information provided is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated. The Company notes that the furnishing of this information is not intended to constitute a determination that the information is material or required by Regulation FD.
Investor Verification Checklist
- Verify the specific features and market impact of the PURE EP Software Version 6 with ACCUVIZ Module by reviewing the attached press release (Exhibit 99.1).
- Confirm that no financial metrics or forward-looking guidance were included in this specific 8-K filing.
- Note that the Company has disclaimed any obligation to update the information contained in this report.